Voloridge Investment Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-82,943
| Closed | -$8.02M | – | 1326 |
|
|
2024
Q1 | $8.02M | Sell |
82,943
-197,118
| -70% | -$20.2M | 0.03% | 534 |
|
|
2023
Q4 | $28.3M | Buy |
280,061
+75,756
| +37% | +$7.31M | 0.11% | 241 |
|
|
2023
Q3 | $20.8M | Sell |
204,305
-307,219
| -60% | -$31.2M | 0.1% | 273 |
|
|
2023
Q2 | $51.6M | Sell |
511,524
-124,655
| -20% | -$12.5M | 0.24% | 99 |
|
|
2023
Q1 | $58.5M | Sell |
636,179
-109,565
| -15% | -$9.57M | 0.29% | 84 |
|
|
2022
Q4 | $67.7M | Sell |
745,744
-405,962
| -35% | -$34.2M | 0.38% | 46 |
|
|
2022
Q3 | $87.5M | Buy |
1,151,706
+263,003
| +30% | +$21.8M | 0.47% | 29 |
|
|
2022
Q2 | $75.1M | Sell |
888,703
-178,864
| -17% | -$15.7M | 0.39% | 56 |
|
|
2022
Q1 | $93.7M | Buy |
1,067,567
+303,722
| +40% | +$26.3M | 0.53% | 21 |
|
|
2021
Q4 | $66.8M | Buy |
763,845
+701,382
| +1,123% | +$58.2M | 0.37% | 40 |
|
|
2021
Q3 | $5.11M | Sell |
62,463
-261,445
| -81% | -$23.5M | 0.03% | 673 |
|
|
2021
Q2 | $29.6M | Buy |
323,908
+159,811
| +97% | +$14.2M | 0.2% | 118 |
|
|
2021
Q1 | $14M | Sell |
164,097
-245,277
| -60% | -$22M | 0.1% | 268 |
|
|
2020
Q4 | $38.7M | Buy |
409,374
+69,079
| +20% | +$6.04M | 0.32% | 64 |
|
|
2020
Q3 | $29.6M | Buy |
340,295
+324,422
| +2,044% | +$28.1M | 0.25% | 97 |
|
|
2020
Q2 | $1.39M | Buy |
15,873
+3,052
| +24% | +$263K | 0.02% | 733 |
|
|
2020
Q1 | $1.06M | Sell |
12,821
-153,992
| -92% | -$13.7M | 0.03% | 496 |
|
|
2019
Q4 | $15.8M | Sell |
166,813
-12,712
| -7% | -$1.14M | 0.31% | 64 |
|
|
2019
Q3 | $15.6M | Buy |
179,525
+166,294
| +1,257% | +$14.9M | 0.27% | 61 |
|
|
2019
Q2 | $1.21M | Buy |
+13,231
| New | +$1.12M | 0.03% | 420 |
|
|
2018
Q3 | – | Sell |
-229,438
| Closed | -$15.5M | – | 420 |
|
|
2018
Q2 | $15.5M | Buy |
229,438
+192,387
| +519% | +$13.3M | 0.42% | 58 |
|
|
2018
Q1 | $2.68M | Buy |
+37,051
| New | +$2.82M | 0.06% | 248 |
|
|
2017
Q4 | – | Sell |
-73,280
| Closed | -$5.64M | – | 571 |
|
|
2017
Q3 | $5.64M | Buy |
+73,280
| New | +$5.53M | 0.13% | 161 |
|
|
2017
Q2 | – | Sell |
-36,536
| Closed | -$2.43M | – | 525 |
|
|
2017
Q1 | $2.43M | Buy |
+36,536
| New | +$2.43M | 0.06% | 298 |
|
|
2016
Q2 | – | Sell |
-386,813
| Closed | -$25.1M | – | 373 |
|
|
2016
Q1 | $25.1M | Buy |
386,813
+140,103
| +57% | +$9.53M | 0.59% | 34 |
|
|
2015
Q4 | $19M | Buy |
246,710
+216,889
| +727% | +$17.2M | 1.36% | 24 |
|
|
2015
Q3 | $2.46M | Buy |
+29,821
| New | +$2.65M | 0.12% | 162 |
|
Other funds holding NVS
CCM
Voloridge Investment Management's NVS Position: Q2 2024 in Review
Voloridge Investment Management sold out of Novartis (NVS) in Q2 2024, closing a stake of 82,943 shares — an estimated $8.02M sold.
Voloridge Investment Management first reported a position in NVS in Q3 2015 and held it in 27 quarters. The position peaked at $93.7M in Q1 2022. 1,306 funds tracked by Wall St. Rank hold NVS as of Q2 2024.
- Voloridge Investment Management reported no remaining Novartis position as of Q2 2024 after selling out during the quarter.
- Voloridge Investment Management sold 82,943 Novartis shares in Q2 2024, an estimated $8.02M.
- Voloridge Investment Management first reported a position in Novartis in Q3 2015 and held it in 27 quarters.
- Voloridge Investment Management's Novartis position peaked at $93.7M in Q1 2022.
- 1,306 funds tracked by Wall St. Rank held Novartis as of Q2 2024.
Based on Voloridge Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.